Format

Send to

Choose Destination
Vaccine. 2013 Dec 31;31 Suppl 7:H80-2. doi: 10.1016/j.vaccine.2013.04.038.

Recommendations for cervical cancer prevention in Central and Eastern Europe and Central Asia.

Author information

1
Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. Electronic address: mario.poljak@mf.uni-lj.si.
2
Department of Obstetrics and Gynecology, Russian Medical Academy of Post-Graduate Education, Moscow, Russia.
3
Faculty of Medicine, University of Belgrade, Department of Obstetrics and Gynecology, Clinical Center of Serbia, Belgrade, Serbia.
4
Section of Cancer Information, International Agency for Research on Cancer, Lyon, France.
5
Department of Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands.
6
Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
7
Cancer Epidemiology Research Program (CERP), IDIBELL, Institut Català d'Oncologia-Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat (Barcelona), Spain.
8
Cancer Epidemiology Research Program (CERP), IDIBELL, Institut Català d'Oncologia-Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat (Barcelona), Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain.
9
Department of Oral Pathology and Oral Radiology, Institute of Dentistry and Medicine Research Laboratory, University of Turku, Turku, Finland.
10
Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium; Laboratory for Cell Biology and Histology, University of Antwerp, Antwerp, Belgium.
PMID:
24332300
DOI:
10.1016/j.vaccine.2013.04.038
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center